Thomas Toy is a Managing Director of Startup Capital Ventures. Tom has been Managing Director of PacRim Venture Partners (www.pacrimpartners.com), a Menlo Park-based venture capital firm specializing in diversified information technology, technology and clean technology companies. Tom presently serves on the boards of directors of several private companies, including portfolio companies HealthCrowd and Phizzle.
Tom is also a Venture Partner/Adviser for ICCP SBI Venture Partners (www.iccpventurepartners.com), which is a limited partner of Startup Capital Ventures Fund I. Previously, Tom was a Partner at SmartForest Ventures and Technology Funding. Tom started his career at Bank of America, where he worked for seven years, where he was a vice president.
Tom has invested in early stage IT, cleantech and healthcare companies as a VC for more than thirty years. He has served on boards of directors of numerous public and private companies. Tom’s current and past investments include SunPower (NASDAQ: SPWR, partially acquired by Total S.A.), UTStarcom (NASDAQ: UTSI), White Electronic Designs (NASDAQ: WEDC, acquired by Microsemi), LifeCell (NASDAQ: LIFC, then acquired by Kinetic Concepts), Physiometrix (NASDAQ: PHYX; then acquired by Hospira), SyStemix (NASDAQ: STMX, then acquired by Novartis), CafePress (NASDAQ: PRSS), U-Systems (acquired by GE Healthcare), and FastSoft (acquired by Akamai), Phoseon and Cloud Cruiser. Tom also served on the boards of directors of Hanwha Q CELLS (NASDAQ: HQCL), before its full acquisition by Hanwha.
Tom graduated from Northwestern University with B.A. and MBA degrees. He taught the New Venture Finance MBA course at San Francisco State’s College of Business, and he is a regular volunteer panelist for the San Francisco Chamber of Commerce’s Job Forum.